# pathway_0193

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **C** — Protein biosynthesis

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | reasoning-supported | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MPPKKSNARNASLLKEAVTNAGRSDTASTAREGSIAATFVSDSDSSTTASGPVDEKVAAVAELITTLTTNAASDKRQSAADDIAKFVEAEGVAQMVKTKILHGIATGLHNTKQPVAREGAITAIETLIKSPVSKQIEPYMITFIPVLLERLSDKAKTVCLAADSALKALITRLTPYATKQVLPLLLAGIEYSQKWQTKVGALELMQSLSKTAPRQMTTAVPDLVPPLSEVMHDTKAEAKNAGRQTMEAICELINNKDIEKFIPALIDTIANPEKVPDTVHLLGATTFVSEVLPPTLAIMVPLLSRGLNERQTAIKRKAAVIIINMCKLVEKPQIIAPFLPRLLPTLEKIQDDVADPECRQVCQNATKILTKVGIPAPGTVMDDSYEFKKLDDKALAYLKKAIGHQQITEIPEAYRPVLEYLEHIAAAMVADGNMDNDDWNGSIIPTLKAFIPTEGTVTNAVKEFRELSFGSNVKEAVAEEEEDDAEELCNCEFSLAYGARVLLNRTHLILKRGHRYGLTGANGSGKSTLMRAIANGQVEGFPPADQLKTVAVEHDLDGAHEHDNKEVQAFVLEDPVYAHLPKETVVNMLESVGFKGPMATRPVGQLSGGWRMKLALARAMLHNADILLLDEPTNHLDVINVAWLQDYLIGLKTVTSIIVSHDSSFLDIVCSDIIHLDNFKLKRYRGNLSKFVEAVPEAKAYYELGAAQQTFRFPEPGMLEGVKTKERAILKVQNAVFQYPGTDRRQLNGVTFQCSLGSRVAVVGPNGAGKSTLIKLLCGVIEPDNGVVWRHPNLRIAYVAQHAFEHIEKHTNLTPNQYIQWRYQTGEDREEMEKAARQISAEEEAAMKKVQVISGEKKVVDSVIGRRKLKNSYEYEVSWVGKLSNENSWLPRDTLIEMGFLKKVQEIDQAEAARQGLARPLTQKEIEKHLSDVGIDSEIGTHSHIRGLSGGQKVKVVIAGAMWQRPHLLVLDEPTNFLDRDSLGALKTAIDAYGGGVIMVTHSREFSEAICKEVWKVDNGELTPTGHNWVSGQGSGPRLEDKNKDEEVFDAFGNKIDVAKQKSKLSGKDLRKKRKEREARRKRGEEVSDDDE

[Multiple Choices]
A. ergot alkaloid biosynthesis. .
B. tetrahydrofolate interconversion. .
C. Protein biosynthesis
D. Antibiotic biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches UniProt entry A0A139AVY4, annotated as elongation factor 3 with the pathway protein biosynthesis; polypeptide chain elongation. The pathway annotation is transferred by similarity (ECO:0000250), so it supports the key but is not direct experimental evidence for this specific protein.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H2](#evidence-h2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 1092-aa sequence has two prominent P-loop NTPase/ABC-like ATPase regions and lacks the features expected of a membrane transporter. That large, soluble tandem-ATPase architecture is consistent with fungal elongation factor 3, which functions in translation, and distinguishes protein biosynthesis from the listed small-molecule and antibiotic biosynthesis pathways.


**Missing item-specific fact**

> No item-specific annotation is supplied; identifying the architecture as eEF3 relies on domain-level biological knowledge rather than remembering this exact sequence’s database entry.


**Reason**

> The sequence offers a concrete architectural clue for a translation-associated factor, although the pathway inference is not equivalent to experimental validation of this protein’s role.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the choices, protein biosynthesis is the pathway consistent with the sequence’s elongation-factor-like architecture.


### Important caveats

- The reviewer-only UniProt evidence confirms an exact sequence match, but that identity and annotation were not available to the evaluated model.
- The pathway evidence is similarity-transferred; the supplied evidence does not establish direct experimental characterization of this protein.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 1092-aa sequence has two prominent P-loop NTPase/ABC-like ATPase regions and lacks the features expected of a membrane transporter. That large, soluble tandem-ATPase architecture is consistent with fungal elongation factor 3, which functions in translation, and distinguishes protein biosynthesis from the listed small-molecule and antibiotic biosynthesis pathways.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "No item-specific annotation is supplied; identifying the architecture as eEF3 relies on domain-level biological knowledge rather than remembering this exact sequence’s database entry.",
    "reason": "The sequence offers a concrete architectural clue for a translation-associated factor, although the pathway inference is not equivalent to experimental validation of this protein’s role."
  },
  "case_id": "pathway_0193",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry A0A139AVY4, annotated as elongation factor 3 with the pathway protein biosynthesis; polypeptide chain elongation. The pathway annotation is transferred by similarity (ECO:0000250), so it supports the key but is not direct experimental evidence for this specific protein."
  },
  "important_caveats": [
    "The reviewer-only UniProt evidence confirms an exact sequence match, but that identity and annotation were not available to the evaluated model.",
    "The pathway evidence is similarity-transferred; the supplied evidence does not establish direct experimental characterization of this protein."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the choices, protein biosynthesis is the pathway consistent with the sequence’s elongation-factor-like architecture."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0193",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry A0A139AVY4, annotated as elongation factor 3 with the pathway protein biosynthesis; polypeptide chain elongation. The pathway annotation is transferred by similarity (ECO:0000250), so it supports the key but is not direct experimental evidence for this specific protein.",
    "evidence_ids": ["C1", "C4", "C5", "H2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 1092-aa sequence has two prominent P-loop NTPase/ABC-like ATPase regions and lacks the features expected of a membrane transporter. That large, soluble tandem-ATPase architecture is consistent with fungal elongation factor 3, which functions in translation, and distinguishes protein biosynthesis from the listed small-molecule and antibiotic biosynthesis pathways.",
    "missing_item_specific_fact": "No item-specific annotation is supplied; identifying the architecture as eEF3 relies on domain-level biological knowledge rather than remembering this exact sequence’s database entry.",
    "reason": "The sequence offers a concrete architectural clue for a translation-associated factor, although the pathway inference is not equivalent to experimental validation of this protein’s role."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the choices, protein biosynthesis is the pathway consistent with the sequence’s elongation-factor-like architecture."
  },
  "important_caveats": [
    "The reviewer-only UniProt evidence confirms an exact sequence match, but that identity and annotation were not available to the evaluated model.",
    "The pathway evidence is similarity-transferred; the supplied evidence does not establish direct experimental characterization of this protein."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A139AVY4 (EF3_GONPJ) is annotated as Elongation factor 3 (eEF3) with the pathway 'Protein biosynthesis; polypeptide chain elongation.' The sequence matches exactly (SHA256 confirmed). The annotation is ECO:0000250 (inferred by similarity from UniProtKB:O93796), not direct experimental evidence, but the functional assignment of eEF3 as a translation elongation factor is well-established. Answer C ('Protein biosynthesis') directly corresponds to the annotated pathway.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H1](#evidence-h1), [H2](#evidence-h2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains at least three tandem AAA+ ATPase domains (identifiable by Walker A motifs: ANGSGKSTLMRAIANGQ, GPNGAGKSTLIKLLCGV, GSGGQKVKVVIAGAMWQR; and Walker B motifs: DEPTNHLDVINVAWLQDYLIGL, DEPTNFLDRDSLGALKTAIDAYGGG). This multi-AAA+ architecture is characteristic of proteins that drive conformational changes through ATP hydrolysis in protein-protein interactions (e.g., ribosome-associated factors), not of small-molecule metabolizing enzymes. Options B (tetrahydrofolate interconversion), A (ergot alkaloid biosynthesis), and D (antibiotic biosynthesis) typically involve enzymes with specific catalytic domains for small-molecule chemistry (folate-binding, PKS/NRPS, cyclases), none of which are present. The tandem AAA+ architecture in a ~1092 aa eukaryotic protein is most consistent with translation machinery (eEF3), pointing to protein biosynthesis.


**Missing item-specific fact**

> Precise identification as eEF3 specifically (rather than another multi-AAA+ protein) requires recognizing the exact domain arrangement and fungal context, but the general AAA+ architecture is sufficient to exclude the small-molecule metabolic pathway distractors.


**Reason**

> A biologist examining the sequence can identify multiple AAA+ ATPase domains and recognize that this architecture is incompatible with the small-molecule enzymatic functions implied by options A, B, and D. The multi-AAA+ tandem arrangement in a eukaryotic protein strongly suggests a role in translation (ribosome-associated ATPase), making 'Protein biosynthesis' the most defensible answer through structural/biochemical reasoning, even without exact protein identification.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The AAA+ ATPase architecture clearly distinguishes this protein from small-molecule metabolic enzymes. Options A, B, and D describe pathways catalyzed by enzymes with specific small-molecule active sites (folate-binding, alkaloid cyclases, NRPS/PKS), which are absent from this sequence. No other option is biologically consistent with a multi-AAA+ protein.


### Important caveats

- The UniProt pathway annotation is ECO:0000250 (inferred by similarity from O93796), not direct experimental evidence for this specific protein.
- The protein is from Gonapodya prolifera (a chytrid fungus); eEF3 is fungal-specific and absent from animals/plants, which is a specialized fact not derivable from sequence alone.
- The reasoning argument (AAA+ architecture excludes small-molecule pathways) is sound but somewhat coarse; a multi-AAA+ protein could theoretically participate in protein degradation or other processes, though those are not offered as options.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains at least three tandem AAA+ ATPase domains (identifiable by Walker A motifs: ANGSGKSTLMRAIANGQ, GPNGAGKSTLIKLLCGV, GSGGQKVKVVIAGAMWQR; and Walker B motifs: DEPTNHLDVINVAWLQDYLIGL, DEPTNFLDRDSLGALKTAIDAYGGG). This multi-AAA+ architecture is characteristic of proteins that drive conformational changes through ATP hydrolysis in protein-protein interactions (e.g., ribosome-associated factors), not of small-molecule metabolizing enzymes. Options B (tetrahydrofolate interconversion), A (ergot alkaloid biosynthesis), and D (antibiotic biosynthesis) typically involve enzymes with specific catalytic domains for small-molecule chemistry (folate-binding, PKS/NRPS, cyclases), none of which are present. The tandem AAA+ architecture in a ~1092 aa eukaryotic protein is most consistent with translation machinery (eEF3), pointing to protein biosynthesis.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Precise identification as eEF3 specifically (rather than another multi-AAA+ protein) requires recognizing the exact domain arrangement and fungal context, but the general AAA+ architecture is sufficient to exclude the small-molecule metabolic pathway distractors.",
    "reason": "A biologist examining the sequence can identify multiple AAA+ ATPase domains and recognize that this architecture is incompatible with the small-molecule enzymatic functions implied by options A, B, and D. The multi-AAA+ tandem arrangement in a eukaryotic protein strongly suggests a role in translation (ribosome-associated ATPase), making 'Protein biosynthesis' the most defensible answer through structural/biochemical reasoning, even without exact protein identification."
  },
  "case_id": "pathway_0193",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H1",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A139AVY4 (EF3_GONPJ) is annotated as Elongation factor 3 (eEF3) with the pathway 'Protein biosynthesis; polypeptide chain elongation.' The sequence matches exactly (SHA256 confirmed). The annotation is ECO:0000250 (inferred by similarity from UniProtKB:O93796), not direct experimental evidence, but the functional assignment of eEF3 as a translation elongation factor is well-established. Answer C ('Protein biosynthesis') directly corresponds to the annotated pathway."
  },
  "important_caveats": [
    "The UniProt pathway annotation is ECO:0000250 (inferred by similarity from O93796), not direct experimental evidence for this specific protein.",
    "The protein is from Gonapodya prolifera (a chytrid fungus); eEF3 is fungal-specific and absent from animals/plants, which is a specialized fact not derivable from sequence alone.",
    "The reasoning argument (AAA+ architecture excludes small-molecule pathways) is sound but somewhat coarse; a multi-AAA+ protein could theoretically participate in protein degradation or other processes, though those are not offered as options."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The AAA+ ATPase architecture clearly distinguishes this protein from small-molecule metabolic enzymes. Options A, B, and D describe pathways catalyzed by enzymes with specific small-molecule active sites (folate-binding, alkaloid cyclases, NRPS/PKS), which are absent from this sequence. No other option is biologically consistent with a multi-AAA+ protein."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0193",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A139AVY4 (EF3_GONPJ) is annotated as Elongation factor 3 (eEF3) with the pathway 'Protein biosynthesis; polypeptide chain elongation.' The sequence matches exactly (SHA256 confirmed). The annotation is ECO:0000250 (inferred by similarity from UniProtKB:O93796), not direct experimental evidence, but the functional assignment of eEF3 as a translation elongation factor is well-established. Answer C ('Protein biosynthesis') directly corresponds to the annotated pathway.",
    "evidence_ids": ["C1", "C4", "C5", "H1", "H2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains at least three tandem AAA+ ATPase domains (identifiable by Walker A motifs: ANGSGKSTLMRAIANGQ, GPNGAGKSTLIKLLCGV, GSGGQKVKVVIAGAMWQR; and Walker B motifs: DEPTNHLDVINVAWLQDYLIGL, DEPTNFLDRDSLGALKTAIDAYGGG). This multi-AAA+ architecture is characteristic of proteins that drive conformational changes through ATP hydrolysis in protein-protein interactions (e.g., ribosome-associated factors), not of small-molecule metabolizing enzymes. Options B (tetrahydrofolate interconversion), A (ergot alkaloid biosynthesis), and D (antibiotic biosynthesis) typically involve enzymes with specific catalytic domains for small-molecule chemistry (folate-binding, PKS/NRPS, cyclases), none of which are present. The tandem AAA+ architecture in a ~1092 aa eukaryotic protein is most consistent with translation machinery (eEF3), pointing to protein biosynthesis.",
    "missing_item_specific_fact": "Precise identification as eEF3 specifically (rather than another multi-AAA+ protein) requires recognizing the exact domain arrangement and fungal context, but the general AAA+ architecture is sufficient to exclude the small-molecule metabolic pathway distractors.",
    "reason": "A biologist examining the sequence can identify multiple AAA+ ATPase domains and recognize that this architecture is incompatible with the small-molecule enzymatic functions implied by options A, B, and D. The multi-AAA+ tandem arrangement in a eukaryotic protein strongly suggests a role in translation (ribosome-associated ATPase), making 'Protein biosynthesis' the most defensible answer through structural/biochemical reasoning, even without exact protein identification."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The AAA+ ATPase architecture clearly distinguishes this protein from small-molecule metabolic enzymes. Options A, B, and D describe pathways catalyzed by enzymes with specific small-molecule active sites (folate-binding, alkaloid cyclases, NRPS/PKS), which are absent from this sequence. No other option is biologically consistent with a multi-AAA+ protein."
  },
  "important_caveats": [
    "The UniProt pathway annotation is ECO:0000250 (inferred by similarity from O93796), not direct experimental evidence for this specific protein.",
    "The protein is from Gonapodya prolifera (a chytrid fungus); eEF3 is fungal-specific and absent from animals/plants, which is a specialized fact not derivable from sequence alone.",
    "The reasoning argument (AAA+ architecture excludes small-molecule pathways) is sound but somewhat coarse; a multi-AAA+ protein could theoretically participate in protein degradation or other processes, though those are not offered as options."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A139AVY4` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 47. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A139AVY4.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:25.720658+00:00.  

```json
"A0A139AVY4"
```

Source SHA-256: `74bd678f72991892cdc46146cb4a86fe3b0f7d2ae19032dcd8c7d805bcb0f848`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A139AVY4.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:25.720658+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Eukaryotic elongation factor 3"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"eEF3"}]}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"P16521","source":"UniProtKB"}],"value":"3.6.4.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Elongation factor 3"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"EF-3"}]}}
```

Source SHA-256: `74bd678f72991892cdc46146cb4a86fe3b0f7d2ae19032dcd8c7d805bcb0f848`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A139AVY4.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:25.720658+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"O93796","source":"UniProtKB"}],"value":"Protein biosynthesis; polypeptide chain elongation"}]}
```

Source SHA-256: `74bd678f72991892cdc46146cb4a86fe3b0f7d2ae19032dcd8c7d805bcb0f848`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A139AVY4?format=txt&versions=47)  
**Locator:** `lines 1-17`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 47 / 1.  
**Retrieved:** 2026-11-02T04:24:29.778395+00:00.  

```text
ID   EF3_GONPJ               Reviewed;        1092 AA.
AC   A0A139AVY4;
DT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.
DT   11-MAY-2016, sequence version 1.
DT   28-JAN-2026, entry version 47.
DE   RecName: Full=Elongation factor 3 {ECO:0000305};
DE            Short=EF-3 {ECO:0000305};
DE            EC=3.6.4.- {ECO:0000250|UniProtKB:P16521};
DE   AltName: Full=Eukaryotic elongation factor 3 {ECO:0000305};
DE            Short=eEF3 {ECO:0000305};
GN   Name=TEF3 {ECO:0000305};
GN   ORFNames=M427DRAFT_119444 {ECO:0000312|EMBL:KXS20890.1};
OS   Gonapodya prolifera (strain JEL478) (Monoblepharis prolifera).
OC   Eukaryota; Fungi; Fungi incertae sedis; Chytridiomycota;
OC   Chytridiomycota incertae sedis; Monoblepharidomycetes; Monoblepharidales;
OC   Gonapodyaceae; Gonapodya.
OX   NCBI_TaxID=1344416 {ECO:0000312|Proteomes:UP000070544};
```

Source SHA-256: `f5583d453bb640e57a634cad7f6f94f5135da55d2628b07b6202933300efe260`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A139AVY4?format=txt&versions=47)  
**Locator:** `lines 50-51`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 47 / 1.  
**Retrieved:** 2026-11-02T04:24:29.778395+00:00.  

```text
CC   -!- PATHWAY: Protein biosynthesis; polypeptide chain elongation.
CC       {ECO:0000250|UniProtKB:O93796}.
```

Source SHA-256: `f5583d453bb640e57a634cad7f6f94f5135da55d2628b07b6202933300efe260`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 193. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
